600381 Qinghai Spring Medicinal Resources Technology
- 2.81
- +0.06+2.18%
Qinghai Spring Medicinal Resources Technology News
ST Spring: Response to the inquiry letter from the controlling shareholder and actual controller of Qinghai Spring
ST Spring: Qinghai Spring Announcement on Abnormal Fluctuations in Stock Trading
Response to the inquiry letter from the controlling shareholder and actual controller of Qinghai Spring
Qinghai Spring Announcement on Abnormal Fluctuations in Stock Trading
Qinghai Spring Wholly-owned Subsidiary Receives Notice of “Administrative Penalty Decision”
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Revised Edition - Deloitte Certified Public Accountants (Special General Partnership) Special Explanation on Issuing Non-Standard Audit Opinion Report on the 2023 Financial Statements of Qinghai Spring Medicinal Resources Technology.
Special explanation on the issues that require the accountant to express opinions in the inquiry letter of Qinghai Spring Medicinal Resources Technology by Daxin Certified Public Accountants (Special General Partnership).
Qinghai Spring Medicinal Resources Technology's announcement regarding the reply to the Shanghai Stock Exchange's Information Disclosure Regulatory Inquiry Letter in the 2023 Annual Report.
Announcement from Qinghai Spring Medicinal Resources Technology regarding the response to the regulatory inquiry letter on information disclosure for the 2023 annual report of Qinghai Spring issued by Shanghai Stock Exchange, which has been extended again.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Notice from Qinghai Spring Medicinal Resources Technology regarding abnormal fluctuations in stock trading.
Reply to Inquiry Letter from Qinghai Spring Medicinal Resources Technology's Shareholder and Actual Controller.
Announcement of Qinghai Spring Medicinal Resources Technology's participation in the 2024 online investor reception day and 2023 annual performance presentation in the Qinghai area.
Analysis
Price Target
No Data
No Data